| Filed On | Filing |
|---|---|
| 09 Oct 2026 |
Form 4: Degnan Chris, Chief Financial Officer
Received 4,483 shares by exercise or conversion · Sold 2,202 shares ($80.8K) |
| 09 Oct 2026 | 144 |
| 09 Sep 2026 |
Form 4: Schoenberg Mark, Chief Medical Officer
Received 1,667 shares by exercise or conversion · Sold 871 shares ($37.4K) |
| 09 Sep 2026 |
Form 4: Smith Jason Drew, General Counsel
Received 3,334 shares by exercise or conversion · Sold 1,519 shares ($64.6K) |
| 09 Sep 2026 | 144 |
| 09 Sep 2026 | 144 |
| 28 Aug 2026 |
Form 4: Robinson James A. Jr., Director
Received 2,000 shares by exercise or conversion |
| 24 Aug 2026 |
Form 4: Schoenberg Mark, Chief Medical Officer
Sold 60,677 shares ($2.85M) |
| 20 Aug 2026 | 144 |
| 20 Aug 2026 | 8-K: Other Events |
| 12 Aug 2026 | SCHEDULE 13G/A |
| 05 Aug 2026 | FORM 10-Q |
| 05 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 10 Jul 2026 |
Form 4: Schoenberg Mark, Chief Medical Officer
Sold 10,000 shares ($400K) |
| 09 Jul 2026 | 144 |
| 24 Jun 2026 |
Form 4: Schoenberg Mark, Chief Medical Officer
Sold 10,000 shares ($350K) |
| 24 Jun 2026 |
Form 4: Wildman Daniel George, Director
Granted 10,000 Stock Option (right ot buy) · Granted 8,000 Restricted Stock Unit |
| 24 Jun 2026 |
Form 4: Robinson James A. Jr., Director
Granted 10,000 Stock Option (right ot buy) · Granted 8,000 Restricted Stock Unit |
| 24 Jun 2026 |
Form 4: Holden Stuart, Director
Granted 20,000 Stock Option (right ot buy) |
| 24 Jun 2026 |
Form 4: Butitta Cynthia M, Director
Granted 10,000 Stock Option (right ot buy) · Granted 8,000 Restricted Stock Unit |
Loading...